ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2025

Abstract Number: 0717

Circulating Bacterial sRNAs are Altered in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Christopher Xavier1, Kevin Byram2, Carol Langford3 and Michelle Ormseth4, 1Meharry Medical College, Nashville, 2Vanderbilt University Medical Center, Nashville, TN, 3Cleveland Clinic, Moreland Hills, OH, 4Vanderbilt University Medical Center, Nashville

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2025

Keywords: ANCA associated vasculitis, Micro-RNA, microbiome, Vasculitis

Session Information

Date: Sunday, October 26, 2025

Title: (0711–0730) Vasculitis – ANCA-Associated Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (AAV) is an autoimmune disease causing small vessel inflammation. Underlying mechanisms of disease are unclear, but the human microbiota may be a contributor. One way that bacteria can affect the immune system is through small RNAs (sRNAs), which are found abundantly in human circulation. The purpose of this study is to determine if circulating bacterial sRNAs are altered in patients with AAV compared to those with and without other inflammatory autoimmune diseases.

Methods: Patients with AAV were recruited from Vanderbilt University Medical Center (VUMC) and Cleveland Clinic. Participants with other inflammatory diseases (rheumatoid arthritis [RA] and systemic lupus erythematosus [SLE], termed here as “inflammatory control”) and control participants were recruited from VUMC. Total RNA was extracted from plasma from all participants and libraries were constructed for next-generation sequencing. sRNAs not aligning to the human genome with up to one mismatch were aligned to bacterial genomes in RefSeq using the TIGER pipeline. sRNA sequences and sRNA counts of bacterial taxa were compared using DESeq2 and the Benjamini-Hochberg method to adjust for multiple comparisons with false discovery rate at 5%.

Results: The study included 31 AAV, 20 inflammatory control (2 RA,18 SLE) and 4 control participants (Table 1). Examining sRNA counts of bacterial taxa, sRNAs aligning to 79 orders (which is the most specific taxonomy to which sRNAs can be assigned with confidence due to the short length and conserved sequences) were altered in AAV versus control and inflammatory control participants (Figure 1). Over half of the orders came from the phyla Pseudomonadota and Actinomycetota. Examining the sRNA sequences, 23 bacterial sRNAs were altered after multiple comparison adjustment in AAV versus control and inflammatory control participants (Figure 2). Of the 23 sequences, 21 were aligned to the phylum Pseudomonadota and all were either tRNA-derived RNAs (tDR) or ribosomal RNA-derived RNAs (rDRs). Among the altered sRNAs were 4 sRNAs with the same base sequence of GGGGCUGUAGCUCAGCUGGGA (thus having the same regulatory seed region, GGGCUGU). These sRNAs were predicted to downregulate key genes involved in T-cell activation and inflammatory processes, including ICOS/ICOSL, CTLA4, NFATC2, CASP3.

Conclusion: The plasma bacterial sRNA composition is altered in patients with AAV compared to control and inflammatory control participants, and the majority of altered sRNAs were from the phylum Pseudomonadota. Among altered bacterial sRNAs were several with a similar base sequence which was predicted to downregulate multiple genes that dappen immune responses, particularly via T cells. Thus, these sRNAs could promote autoimmune inflammation. Future mechanistic studies will be needed to confirm these findings.

Supporting image 1Table. Participant demographics

Supporting image 2Figure 1: Cladogram representing significantly altered phylum, class, and order level taxonomy of sRNA counts. Those order-level taxa counts with significant alteration (adjusted P value < 0.05) in both AAV versus control and versus inflammatory control participants were included.

Supporting image 3Figure 2: Volcano plots of altered plasma bacterial sRNAs in (A) AAV versus control and (B) AAV versus inflammatory control participants. Dots indicate one sRNA sequence with colored dots being those with a fold difference >1.5 and unadjusted p value < 0.05. (C) Venn diagram illustrating specific and common sRNA sequences altered in AAV versus controls and versus inflammatory controls after multiple comparison adjustment.


Disclosures: C. Xavier: None; K. Byram: None; C. Langford: AbbVie/Abbott, 12, Non-paid consultant, AstraZeneca, 5, 12, Non-paid consultant, Bristol-Myers Squibb(BMS), 5, 12, Non-paid consultant, GlaxoSmithKlein(GSK), 5, NS Pharma, 5; M. Ormseth: None.

To cite this abstract in AMA style:

Xavier C, Byram K, Langford C, Ormseth M. Circulating Bacterial sRNAs are Altered in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/circulating-bacterial-srnas-are-altered-in-patients-with-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/circulating-bacterial-srnas-are-altered-in-patients-with-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology